Randomized phase 2 trial of the Vincristine-Irinotecan combination with or without Temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: an EpSSG/ITCC trial.
Collections
Research team
Sarcoma Clinical Trials in children and young people
Sarcoma Clinical Trials in children and young people
Language
eng
Date accepted
2021-06-17
License start date
2021-06-17
Citation
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology